01-06-2021 | NSCLC | Research Report
Anti-PD-1 antibody-mediated activation of type 17 T-cells undermines checkpoint blockade therapy
Published in: Cancer Immunology, Immunotherapy | Issue 6/2021
Login to get access01-06-2021 | NSCLC | Research Report
Published in: Cancer Immunology, Immunotherapy | Issue 6/2021
Login to get access